Login to Your Account



Endocyte, AcelRx on Deck

Pacira Cuts Price, Raises $42M in First Biotech IPO of 2011

By Jennifer Boggs


Friday, February 4, 2011
Pacira Pharmaceuticals Inc.'s $42 million initial public offering – the first biotech IPO out of the gate in 2011 – looks a lot like the pricings of 2010.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription